Navigation Links
Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
Date:12/10/2013

NEW ORLEANS, Dec. 10, 2013 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced results of 40 clinical, non-clinical and pre-clinical presentations on ibrutinib (IMBRUVICA) at the 55TH Annual meeting of the American Society of Hematology (ASH) held in New Orleans, Dec 7 - 10, 2013. There were seven presentations of clinical data, of which five were oral presentations, including one "Best of ASH" presentation on Waldenstrom's macroglobulinemia (WM). In total, 33 additional pre-clinical and non-clinical presentations provided new discoveries using ibrutinib; seven of these were oral presentations. The presentations further elucidated the mechanism of action of ibrutinib and its effect in the tumor microenvironment and provided data on quality of life changes. Results covered various B-cell malignancies: chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), WM, and non-Hodgkin lymphoma (NHL).

"The breadth of data presented at ASH this year demonstrates the scientific community's interest in ibrutinib and builds on the clinical responses seen with ibrutinib as a backbone of combination therapy and as a single agent in multiple B-cell malignancies," said Jesse McGreivy, M.D., Chief Medical Officer, Pharmacyclics. "This year's data explain ibrutinib's effect on the quality of life for patients and build on impressive efficacy and safety results, independent of cytogenetic risk factors. We also now have long-term follow-up in CLL, which suggests continuation of the efficacy and a decrease in overall and severe adverse events."

Clinical Trial Presentation Highlights

Chronic Lymphocytic Leukemia

-POSTER PRESENTATION- Abstract #4163:
The Bruton's Tyrosine Kinase (BTK) Inhibitor Ibruti
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. WuXi PharmaTech to Partner with Pharmacyclics
2. Pharmacyclics Reports Third Quarter 2013 Results
3. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
4. Pharmacyclics Reports Second Quarter 2013 Results
5. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
6. Pharmacyclics Reports First Quarter 2013 Results
7. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
8. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
9. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
10. Pharmacyclics, Inc. Prices Public Offering of Common Stock
11. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BEDFORD, Mass. , Sept. 1, 2015 ... investigating whether certain officers and directors of ... Act of 1934.  ConforMIS is a medical technology company ... manufacture, and sell joint replacement implants that are individually ... View this press release on the law ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015  Amgen ... collaboration with Novartis in the areas of Alzheimer,s ... entry into Alzheimer,s disease by teaming up with ... disease program directed at genetically predisposed individuals at ... Amgen to focus on the commercialization of its ...
(Date:9/1/2015)... -- AccuTec Blades, Inc. today announced the acquisition of Edgewell ... in May 2015 its intent to discontinue its industrial ... and Obregon, Mexico . Today,s announcement ... Rick Gagliano , the newly-appointed President and ... name, AccuTec Blades, reflects the precision and accuracy of ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2
... (NYSE: SYK ) announced today that its Board of Directors has ... July 30, 2010 to shareholders of record at the close of business ... , , ... is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing ...
... ,, MINNEAPOLIS , June 21 HeartSine Technologies Ltd. recently ... of the most exciting companies with operations in the U.S. and Ireland ... Other companies on this year,s ... biggest-selling newspaper serving Irish America , included Aon Corporation, BNY Mellon, Bimeda, ...
Cached Medicine Technology:HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference 2
(Date:9/1/2015)... ... September 01, 2015 , ... ... Vending Machine,” is still strongly maintaining her firm’s success in the hair care ... In her upcoming city-to-city tour, Ellis will be providing “Look and learn” live ...
(Date:9/1/2015)... ... 2015 , ... OncLive® today announced it is ... World Report, to provide breaking news and information about the hospital’s pioneering research ... which provides oncologists resources and information?they need to deliver the best care for?their?patients, ...
(Date:9/1/2015)... ... ... The Jerry Segal Classic to benefit the patients of Magee Rehabilitation Hospital ... Lafayette Hill, PA. Over the past 26 years, the Classic, organized by the Friends ... to support patients and their families during their time at Magee Rehabilitation Hospital. ...
(Date:9/1/2015)... , ... September 01, 2015 , ... With former IBMers ... and Math) disciplines since its inception more than 35 years ago. A pilot program ... and their teachers - and, not just those intent on pursuing careers in these ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... announced the release of version 5.2 of the FirstSpirit Content Management System with ... initiative. With the new version of FirstSpirit, companies will be well on their ...
Breaking Medicine News(10 mins):Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3
... Month, which is just ahead in February, new mortality ... (CDC) shows that, since 1999, coronary heart disease and ... and 24.4 percent, respectively. This means that the ... from coronary heart disease has been achieved, and for ...
... Increased exercise capacity reduces the risk of death in ... of the American Heart Association. , The government-supported Veterans ... known to assess the link between fitness and mortality. ... relatively moderate levels of physical activity like brisk ...
... currently evaluate a patients risk for heart disease, stroke ... assessment tool could gauge risk of overall ,or global, ... time, according to a study published in Circulation: Journal ... is particularly well suited for use by office-based primary ...
... Vice President, Managing Director, NEW YORK, Jan. 22 ... that Marcy Leger has joined the firm as,Executive Vice ... as a result of the tremendous growth of the ... Euro RSCG Life LM&P New,York and Chicago., "We,re ...
... On February 18, Dorsey,Schools will open its ... Hills, Michigan. The Farmington Hills facility has the ... community-style setting.,This approximately 7,500 square-foot campus will focus ... evening classes in medical,assisting and patient care technician ...
... through the Emergency E-Response from VoiceGate, a Division of ... ... /PRNewswire/ - VoiceGate, a Division of IgeaCare,Systems, Inc., unveils its ... Campus Alert is introduced as a module to the VoiceGate,Emergency ...
Cached Medicine News:Health News:Heart and stroke death rates steadily decline; risks still too high 2Health News:Heart and stroke death rates steadily decline; risks still too high 3Health News:Heart and stroke death rates steadily decline; risks still too high 4Health News:Daily exercise dramatically lowers men's death rates 2Health News:Daily exercise dramatically lowers men's death rates 3Health News:A simplified scoring system may predict overall CVD risk, individual CVD components risk 2Health News:Euro RSCG Life LM&P Announces Growth of Leadership Team 2Health News:Dorsey Schools, Detroit Area's Preeminent Career Training School, Opens a Fifth Campus in Farmington Hills 2Health News:"Campus Alert by VoiceGate" introduced at Internet Telephony(R) Conference and Expo 2Health News:"Campus Alert by VoiceGate" introduced at Internet Telephony(R) Conference and Expo 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: